News & Updates

Leuprolide acetate maintains QOL scores in prostate cancer patients despite worsening condition
Leuprolide acetate maintains QOL scores in prostate cancer patients despite worsening condition
05 Oct 2021
Collagen proportionate area predicts long-term, but not short-term mortality in alcoholic hepatitis
Collagen proportionate area predicts long-term, but not short-term mortality in alcoholic hepatitis
04 Oct 2021

Collagen proportionate area (CPA) is a good predictor of long-term mortality in alcoholic hepatitis (AH) patients regardless of their abstinence from alcohol, a recent study has found. However, CPA seems to have no clear interaction with short-term mortality.

Collagen proportionate area predicts long-term, but not short-term mortality in alcoholic hepatitis
04 Oct 2021
COVID-19 in childhood cancer patients: What are the risk factors?
COVID-19 in childhood cancer patients: What are the risk factors?
04 Oct 2021
Singapore lags in latent tuberculosis screening among HIV-positive individuals
Singapore lags in latent tuberculosis screening among HIV-positive individuals
04 Oct 2021 byJairia Dela Cruz

Latent tuberculosis (TB) infection screening in Singapore, a nation with intermediate TB burden, appears to be below average among individuals who are HIV-positive, a study has revealed.

Singapore lags in latent tuberculosis screening among HIV-positive individuals
04 Oct 2021
Acute abdomen, appendicitis may occur in children with COVID-19, MIS-C
Acute abdomen, appendicitis may occur in children with COVID-19, MIS-C
04 Oct 2021 byStephen Padilla

Paediatric patients with COVID-19 or multisystem inflammatory syndrome in children (MIS-C) may develop acute abdomen, with or without appendicitis, a study in Latin America has found.

Acute abdomen, appendicitis may occur in children with COVID-19, MIS-C
04 Oct 2021
Varenicline plus naltrexone may aid in smoking cessation, drinking reduction
Varenicline plus naltrexone may aid in smoking cessation, drinking reduction
04 Oct 2021

Varenicline alone is an adequate therapy for smoking cessation in heavy-drinking smokers, but combining it with naltrexone may provide benefits in terms of drinking outcomes, particularly during the 12-week period of active medication treatment, suggests a study.

Varenicline plus naltrexone may aid in smoking cessation, drinking reduction
04 Oct 2021